Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Kubota Pharmaceutical Holdings Co PS Ratio?
Kubota Pharmaceutical Holdings CoTSE:4596 -6.85%39 PS Ratio is 507.46 as of Jul. 16, 2026, which is 70% above its 10-year median of 298.24. GuruFocus rates TSE:4596 with a GF Score™ of 39/100 and a GF Value™ of 円16.35 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 930 Biotechnology companies, Kubota Pharmaceutical Holdings Co ranks worse than 94.09% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Kubota Pharmaceutical Holdings Co's share price is 円68.00.
Kubota Pharmaceutical Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円0.13. Hence, Kubota Pharmaceutical Holdings Co's PS Ratio for today is 507.46.
During the past 11 years, Kubota Pharmaceutical Holdings Co's highest 3-Year average Revenue per Share Growth Rate was 25.70% per year. The lowest was -6.70% per year. And the median was 9.50% per year.
Back to Basics: PS Ratio
Kubota Pharmaceutical Holdings Co (TSE:4596) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Kubota Pharmaceutical Holdings Co PS Ratio Related Terms
Kubota Pharmaceutical Holdings Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Kubota Pharmaceutical Holdings Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kubota Pharmaceutical Holdings Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kubota Pharmaceutical Holdings Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Kubota Pharmaceutical Holdings Co's PS Ratio falls into.
Kubota Pharmaceutical Holdings Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Kubota Pharmaceutical Holdings Co's Share Price of today is 円68.00. Kubota Pharmaceutical Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.13.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Kubota Pharmaceutical Holdings Co (TSE:4596) has a PS Ratio of 507.46 as of Jul. 16, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. This is 70% above median its historical median of 298.24. Over the past decade, Kubota Pharmaceutical Holdings Co's PS Ratio has ranged from 88.08 to 2,571.43. According to the industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #875 out of 930 companies in the Biotechnology industry, placing it in the top 94.1%.
Is Kubota Pharmaceutical Holdings Co's PS Ratio too high?
Kubota Pharmaceutical Holdings Co's current PS Ratio of 507.46 is 70% above median its 10-year median of 298.24. Over the past 10 years, this metric has ranged from a low of 88.08 to a high of 2,571.43. The Biotechnology industry median PS Ratio is 9.66. Kubota Pharmaceutical Holdings Co's value of 507.46 is 5155.9% above this industry median. Based on the distribution chart, Kubota Pharmaceutical Holdings Co ranks #875 out of 930 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #875 out of 930 companies for PS Ratio. This places Kubota Pharmaceutical Holdings Co in the lower half of its industry. The industry median PS Ratio is 9.66. Kubota Pharmaceutical Holdings Co's value of 507.46 is 5155.9% above this benchmark. Historically, Kubota Pharmaceutical Holdings Co's own PS Ratio has ranged from 88.08 to 2,571.43 over the past decade. While the company's 10-year median is 298.24 vs. the industry median of 9.66, Kubota Pharmaceutical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.66, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kubota Pharmaceutical Holdings Co's current PS Ratio of 507.46 is 5155.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kubota Pharmaceutical Holdings Co's current PS Ratio is 507.46, which is 70% above median its own 10-year median of 298.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円16.35, compared to a current price of 円68.00 — trading 315.9% above its estimated fair value. The current PS Ratio is 507.46, which is 70% above median its 10-year median of 298.24 and 5155.9% above the Biotechnology industry median of 9.66. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current PS Ratio is 507.46 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued.
The current stock price of 円68.00 is trading 315.9% above its estimated GF Value™ of 円16.35.
GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4596:
PS Ratio: 507.46 (70% above median its 10-year median of 298.24)
GF Value™: 円16.35 vs. price of 円68.00 (315.9% above fair value)
Industry Position: 5155.9% above the Biotechnology median (#875 of 930)
No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kubota Pharmaceutical Holdings Co Business Description
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
39GF Score
Get the complete analysis for TSE:4596
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4596 has been successfully added to your 
